Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2010
08/26/2010US20100216818 Inhibitors of Post-Amadori Advanced Glycation End Products
08/26/2010US20100216811 Furo[3. 2-b] pyrrol derivatives
08/26/2010US20100216808 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
08/26/2010US20100216790 Imidazopyridine-derivatives as inducible no-synthase inhibitors
08/26/2010US20100216789 Rho-kinase inhibitors
08/26/2010US20100216786 New compounds
08/26/2010US20100216785 Pharmaceutical compositions
08/26/2010US20100216781 mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCIATED WITH THE mTOR/PI3K/AKT PATHWAY
08/26/2010US20100216778 Pain remedy containing rock inhibitor
08/26/2010US20100216761 Novel azetidinones useful as inhibitors of elastase
08/26/2010US20100216756 Compositions and methods for suppressing endometrial proliferation
08/26/2010US20100216748 Pyrrole Derivatives and Their Methods of Use
08/26/2010US20100216747 Preventive agent or therapeutic agent for disease caused by abnormal bone metabolism
08/26/2010US20100215759 Pharmaceutical compounds
08/26/2010US20100215743 Composition and drug delivery of bisphosphonates
08/26/2010US20100215741 Pharmaceutical compounds
08/26/2010US20100215731 Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
08/26/2010US20100215715 Gel delivery system for tissue repair
08/26/2010US20100215677 Pdz domain interactions and lipid rafts
08/26/2010US20100215667 Methods and compositions of treatment for modulating the immune system of animals
08/26/2010US20100215664 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6 -mediated signalling
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides
08/26/2010US20100215655 Angiogenesis-inhibiting chimeric proteins and the use
08/26/2010US20100215654 Methods of treating Osteoarthritis with IL-6 Antagonists
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215631 Anti-inflammatory composition comprising glycine and lactoferrin and the use thereof
08/26/2010US20100215624 Pharmaceutical Compositions for Treating Rheumatoid Arthritis Comprising Semi-Mature Dendritic Cell
08/26/2010US20100215623 Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
08/26/2010US20100215614 Enterostatin as Inhibitor of Angiogenesis
08/26/2010CA2789515A1 Treatment of chronic inflammatory conditions
08/26/2010CA2753280A1 Anti-human .alpha.9 integrin antibody and use thereof
08/25/2010EP2221360A1 Lactic acid bacterium having effect of lowering blood uric acid level
08/25/2010EP2221359A1 Lactic acid bacteria having action of lowering blood uric acid level
08/25/2010EP2221314A1 A soluble tumor necrosis factor receptor mutant
08/25/2010EP2221308A1 Benzazepinone compound
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2220029A1 Novel compounds
08/25/2010EP2219669A1 Compositions and methods for treatment of autoimmune and allergic diseases
08/25/2010EP2219622A1 Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
08/25/2010EP1480627B1 Methods of reducing angiogenesis
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010EP1042286B1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
08/25/2010CN201558333U Anti-hyperosteogeny pill coated with film-coating
08/25/2010CN201558332U Arthritis black plaster
08/25/2010CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors
08/25/2010CN101815710A Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
08/25/2010CN101815535A molecules for targeting compounds to various selected organs or tissues
08/25/2010CN101812474A Preparation method and application of osteoporotegerin-heat-shock protein 65-fused protein
08/25/2010CN101812118A Specific binding agents of human angiopoietin-2
08/25/2010CN101810855A II-type collagen joint cartilage fluid and preparation method thereof
08/25/2010CN101810825A Medicament for treating femoral head necrosis and preparation method thereof
08/25/2010CN101810807A Chinese medicinal liquor for treating rheumatoid arthritis and preparation method thereof
08/25/2010CN101810786A Plaster for treating osteoarthropathy
08/25/2010CN101810785A Plaster for treating cervical spondylosis
08/25/2010CN101810756A Plaster for treating lumbar
08/25/2010CN101810747A Chinese medicinal preparation for treating cervical spondylosis and lumbar disc herniation
08/25/2010CN101810739A Anti-osteoarthritis Chinese medicament compound and use thereof
08/25/2010CN101810732A Injury bone growing particle traditional Chinese medicine preparation and production method thereof
08/25/2010CN101810731A Medicinal liquor for curing protrasion of lumbar intervertebral disci
08/25/2010CN101810727A Chinese medicament for treating various painful diseases and preparation method thereof
08/25/2010CN101810715A New application of fructus evodiae and extracts and compounds thereof
08/25/2010CN101810709A Medicament for treating rheumatism
08/25/2010CN101810686A Compatible composition for treating rheumatoid arthritis and preparation method thereof
08/25/2010CN101810685A Chinese medicinal composition for treating gonitis and preparation method thereof
08/25/2010CN101810647A Method for supercritical CO2 extraction of total flavonoids of athyrium multidentatum ching
08/25/2010CN101810602A Application of compound 3,5,2',4'-tetrahydroxy chalcone in preparation of drug for preventing and treating hyperuricemia and gout
08/25/2010CN101810572A Nimesulide suspension and preparation method thereof
08/25/2010CN101810525A Multifunctional shape-protecting health-care medicinal pillow for infant
08/25/2010CN101352480B Chinese medicinal composition for treating osteoporosis and preparation method thereof
08/25/2010CN101065119B Ameliorant for renal insufficiency
08/24/2010US7781584 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
08/24/2010US7781487 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors
08/24/2010US7781450 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer
08/24/2010US7781440 Neurodegenerative diseases caused by GSK3 such as Alzheimer's disease
08/24/2010US7781407 Reacting a gluconic acid with lactic acid in the presence of calcium hydroxide and water to obtain a calcium gluconolactate molecule having the formula HO-CH2-(CHOH)4-COO-Ca-OOC-CH(-OH)-CH3 with molecular weight of 324.2994; physical and chemical properties; nutraceuticals
08/24/2010CA2572897C Pharmaceutical composition for the treatment of bone fracture
08/24/2010CA2557368C Polynucleotide participating in rheumatoid arthritis and utilization of the same
08/24/2010CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/24/2010CA2460135C Use of pyridazinone compounds as phosphodiesterase iv inhibitors for treating cancer and other diseases
08/19/2010WO2010092962A1 Hetero ring derivative
08/19/2010WO2010075263A3 Compounds and methods for enhancing erythropoiesis
08/19/2010WO2010026596A3 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses
08/19/2010WO2009135581A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
08/19/2010US20100211183 Chemical Mechanical Vapor Deposition Device for Production of Bone Substitute Material
08/19/2010US20100210838 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activity
08/19/2010US20100210733 Composition for Prevention or Treatment of Bone Metabolism Disorder Comprising D-Pinitol as an Active Ingredient
08/19/2010US20100210705 Pyrrole and Isoindole Carboxamide Derivatives as P2X7 Modulators
08/19/2010US20100210699 Imidazolidine derivatives, uses therefor, preparation thereof and compositions comprising such
08/19/2010US20100210685 Novel Substituted Indoles
08/19/2010US20100210678 Tricyclic androgen receptor modulator compounds and methods
08/19/2010US20100210658 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
08/19/2010US20100210645 Certain Chemical Entities, Compositions and Methods
08/19/2010US20100210641 Organic Compounds
08/19/2010US20100210637 Heteroaryloxy nitrogenous saturated heterocyclic derivative
08/19/2010US20100210632 Novel pyrrolinone derivative and pharmaceutical composition comprising the same
08/19/2010US20100210629 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
08/19/2010US20100210627 Pyrazine compounds, their use and methods of preparation
08/19/2010US20100210619 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis
08/19/2010US20100210593 Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 820